ESR1 and breast neoplasm: Obviously, xenograft models will be required to test whether TSC inhibits the growth of ERα-positive breast tumors invivo, and establishing rat or rabbit models of mammary hyperplasia on which to test the therapeutic effects of TSC and its underlying functional mechanisms may also prove worthwhile.